HomeENBI • CNSX
add
Entheon Biomedical Corp
Previous close
$0.10
Year range
$0.070 - $0.14
Market cap
1.39M CAD
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Feb 2026info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 89.06K | -40.31% |
Net income | -99.72K | 31.51% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Feb 2026info | Y/Y change |
|---|---|---|
Cash and short-term investments | 267.60K | -49.04% |
Total assets | 284.13K | -49.55% |
Total liabilities | 59.82K | -5.72% |
Total equity | 224.31K | — |
Shares outstanding | 20.61M | — |
Price to book | 10.00 | — |
Return on assets | -69.80% | — |
Return on capital | -81.20% | — |
Cash Flow
Net change in cash
| (CAD) | Feb 2026info | Y/Y change |
|---|---|---|
Net income | -99.72K | 31.51% |
Cash from operations | -54.24K | 51.28% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -54.24K | -113.95% |
Free cash flow | -10.17K | 82.75% |
About
Founded
Jun 2019
Headquarters
Website
Employees
1
